v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 113,942,156 $ 61,890,048
Accounts Receivable 17,425,680 706,925
Inventories 1,371,738 65,655
Receivable from noncontrolling interests 0 27,556
Note receivable 31,189,144 0
Lease receivable - current 16,733 0
Prepaid expenses and other current assets 10,099,525 3,053,478
Total current assets 174,044,976 65,743,662
Property and equipment, net 30,930,235 22,354,377
Operating lease right-of-use assets, net 971,658 1,122,134
Deferred tax assets 68,008 31,847
Intangible assets 1,190,562 0
Goodwill 6,849,119 3,168,101
Lease receivable - noncurrent 410,223 0
Equity method investments 1,322,900 0
Other investments 5,000,000 0
Other noncurrent assets 5,102,480 1,927,867
Total assets 225,890,161 94,347,988
Current liabilities:    
Accounts payable 3,424,698 1,021,393
Accrued expenses 3,655,761 2,275,681
Debt - current 12,401,279 939,110
Finance lease liabilities - current 166,459 125,862
Operating lease liabilities - current 468,569 557,676
Deferred revenue 882,000 882,000
Due to related parties 3,438,275 0
Other current liabilities 3,666,092 1,256,549
Share liability 220,635 0
Total current liabilities 28,323,768 7,058,271
Deferred tax liabilities 307,807 0
Convertible notes payable, at fair value 97,975,479 33,433,184
Debt - noncurrent 1,534,686 1,441,286
Finance lease liabilities - noncurrent 492,103 560,328
Operating lease liabilities - noncurrent 617,988 688,479
Other noncurrent liabilities 34,353 0
Total liabilities 129,286,184 43,181,548
Commitments and contingencies (Note 9)
Stockholders' equity    
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2025 and December 31, 2024 0 0
Common stock, $0.01 par value; 500,000,000 shares authorized, 93,376,629 and 72,068,059 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 933,766 720,681
Additional paid-in capital 224,740,838 105,515,005
Accumulated deficit (152,555,942) (56,172,881)
Accumulated other comprehensive income (loss) 949,855 (2,164,313)
Total stockholders' equity attributed to ASP Isotopes Inc. stockholders 74,068,517 47,898,492
Noncontrolling interests in consolidated subsidiaries 22,535,460 3,267,948
Total stockholders' equity 96,603,977 51,166,440
Total liabilities and stockholders' equity $ 225,890,161 $ 94,347,988

Source

HTML PDF
ZIP